Europe Point of Care (PoC) Diagnostics Market Size Worth USD 13.61 Billion by 2034 | CAGR: 3.92%

The europe Point-of-Care (PoC) diagnostics market size is expected to reach USD 13.61 billion by 2034, according to a new study by Polaris Market Research. The report “Europe Point of Care (PoC) Diagnostics Market Share, Size, Trends, Industry Analysis Report: By Product (Glucose Testing, Hb1Ac Testing, Coagulation), By Mode of Prescription, By End Use and By Country; Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Point-of-Care (PoC) diagnostics are streamlined medical testing options that provide rapid, real-time results at the patient point of care, facilitating immediate clinical decision-making. The Europe PoC diagnostics market is experiencing growth with the ongoing shift towards self-testing, where there is an option for patients to choose easy-to-use, accessible options for diagnostic testing. This shift to self-testing indicates a desire for greater accountability in healthcare decisions, a frequently requested shift where early identification of disease is prioritized. Self-testing also enhances patient engagement, which supports improved health outcomes because timely feedback to patients cannot be delayed further by centralized laboratory-based systems.

Questions? Request a sample or make an inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/europe-point-of-care-diagnostics-market/request-for-sample

The ongoing evolution and development of PoC technologies continue to boost market growth through innovations. For example, advancements in the accuracy of testing platforms, miniaturization of devices, and more effective integration of PoC platform systems or software with digital health tools actively expand PoC applications. Therefore, PoC diagnostic solutions will continue to become more user-friendly and dependably used in different healthcare settings. Similarly, as efforts to ensure connectivity and data-sharing capabilities continue to grow, PoC diagnostics will become a preferred alternative in future healthcare delivery models that prioritize personalized and preventative approaches. Together, these developments also illustrate a positive trajectory for PoC diagnostics and planned services continuing to evolve as largely technology-enabled patient-centered solutions.

EEurope Point-of-Care (PoC) diagnostics Market Report Highlights

• In terms of product, in 2024, infectious diseases held the largest share at 57.65%, boosted by increasing cases and the need for rapid and accurate diagnostic solutions to control outbreaks.
• Based on mode of prescription, the over-the-counter segment is expected to grow faster, driven by a clear consumer shift to home-based healthcare and the proliferation of self-monitoring approaches.
• The Germany PoC diagnostics market accounted for 17.91% revenue share in 2024 driven by increasing adoption of diagnostic technologies and rising healthcare infrastructure.
• The UK is expected to be the fastest growing market, driven by increasing interest in home-testing solutions additionally, the wider transition to decentralized healthcare.
• A few global key market players include bioMérieux; Boditech Med Inc.; EKF Diagnostics; Grifols; HORIBA, Ltd.; Nova Biomedical; Qiagen; Roche Diagnostics; Siemens Healthineers; and Werfen.

Polaris Market Research has segmented the market report on the basis of product, mode of prescription, end use, and country:

By Product Outlook (Revenue, USD Billion, 2020–2034)

• Glucose Testing
• Hb1Ac Testing
• Coagulation
• Fertility
• Infectious Diseases
  • HIV
  • Clostridium Difficile
  • HBV
  • Pneumonia or Streptococcus Associated Infections
  • Respiratory Syncytial Virus (RSV)
  • HPV
  • Influenza/Flu
  • HCV
  • MRSA
  • TB and Drug-Resistant TB
  • HSV
  • Others
• Cardiac Markers
• Thyroid Stimulating Hormone
• Hematology
• Primary Care Systems
• Decentralized Clinical Chemistry
• Feces
• Lipid Testing
• Cancer Marker
• Blood Gas/Electrolytes
• Ambulatory Chemistry
• Drug Abuse Testing
• Urinalysis

By Mode of Prescription (Revenue, USD Billion, 2020–2034)

• OTC
• Prescription-based

By End Use Outlook (Revenue, USD Billion, 2020–2034)

• Clinics
  • Physician Office
  • Pharmacy & Retail Clinics
  • Non-practice Clinics
  • Urgent Care Clinic
• Hospitals
• Home
• Assisted Living Healthcare Facilities
• Laboratory

By Country Outlook (Revenue, USD Billion, 2020–2034)

• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia

Rest of Europe